Arax Advisory Partners’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.02K Sell
122
-54
-31% -$3.69K ﹤0.01% 2496
2025
Q4
$10.4K Sell
176
-31
-15% -$1.68K ﹤0.01% 2447
2025
Q3
$11.4K Sell
207
-327
-61% -$17K ﹤0.01% 2534
2025
Q2
$23K Buy
+534
New +$20.6K ﹤0.01% 1600
2024
Q4
Sell
-47
Closed -$1.83K 2633
2024
Q3
$1.83K Hold
47
﹤0.01% 2100
2024
Q2
$2.06K Buy
+47
New +$2.27K ﹤0.01% 1959
2020
Q4
$17K Hold
218
﹤0.01% 518
2020
Q3
$11K Hold
218
﹤0.01% 533
2020
Q2
$11K Hold
218
﹤0.01% 529
2020
Q1
$8K Hold
218
﹤0.01% 536
2019
Q4
$19K Hold
218
0.01% 420
2019
Q3
$18K Hold
218
0.01% 417
2019
Q2
$23K Buy
+218
New +$21.9K 0.01% 396
2018
Q4
$18K Hold
218
0.01% 383
2018
Q3
$22K Hold
218
0.01% 393
2018
Q2
$17K Hold
218
0.01% 309
2018
Q1
$16K Hold
218
0.01% 294
2017
Q4
$15K Hold
218
0.01% 302
2017
Q3
$13K Hold
218
0.01% 312
2017
Q2
$13K Hold
218
0.01% 330
2017
Q1
$13K Hold
218
0.01% 312
2016
Q4
$12K Buy
+218
New +$10.5K 0.01% 306

Other funds holding NGVT

Arax Advisory Partners's NGVT Position: Q1 2026 in Review

Arax Advisory Partners reduced its Ingevity (NGVT) stake by 31% in Q1 2026, selling an estimated $3.69K and leaving 122 shares worth $9.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

Arax Advisory Partners first reported a position in NGVT in Q4 2016 and has held it in 22 quarters since. The position peaked at $23K in Q2 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Arax Advisory Partners held 122 shares of Ingevity worth $9.02K as of Q1 2026.
  • Arax Advisory Partners sold 54 Ingevity shares in Q1 2026, an estimated $3.69K.
  • Ingevity made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2496 holding.
  • Arax Advisory Partners first reported a position in Ingevity in Q4 2016 and has held it in 22 quarters since.
  • Arax Advisory Partners's Ingevity position peaked at $23K in Q2 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.